drugset / Trial / NCT02155881
Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to explore the efficacy and safety of Ciclesonide Nasal Spray 200 microgram (mcg) once daily in the treatment of seasonal allergic rhinitis (SAR) in Russian participants.
Timeline
- Start
- 2014-08
- Primary completion
- 2014-10
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciclesonide | Other / unclassified | 200 ug | Intranasal |